316 related articles for article (PubMed ID: 24702987)
1. BDNF plasma levels after antidepressant treatment with sertraline and transcranial direct current stimulation: results from a factorial, randomized, sham-controlled trial.
Brunoni AR; Machado-Vieira R; Zarate CA; Vieira EL; Vanderhasselt MA; Nitsche MA; Valiengo L; Benseñor IM; Lotufo PA; Gattaz WF; Teixeira AL
Eur Neuropsychopharmacol; 2014 Jul; 24(7):1144-51. PubMed ID: 24702987
[TBL] [Abstract][Full Text] [Related]
2. Assessment of non-BDNF neurotrophins and GDNF levels after depression treatment with sertraline and transcranial direct current stimulation in a factorial, randomized, sham-controlled trial (SELECT-TDCS): an exploratory analysis.
Brunoni AR; Machado-Vieira R; Zarate CA; Vieira EL; Valiengo L; Benseñor IM; Lotufo PA; Gattaz WF; Teixeira AL
Prog Neuropsychopharmacol Biol Psychiatry; 2015 Jan; 56():91-6. PubMed ID: 25172025
[TBL] [Abstract][Full Text] [Related]
3. Impact of 5-HTTLPR and BDNF polymorphisms on response to sertraline versus transcranial direct current stimulation: implications for the serotonergic system.
Brunoni AR; Kemp AH; Shiozawa P; Cordeiro Q; Valiengo LC; Goulart AC; Coprerski B; Lotufo PA; Brunoni D; Perez AB; Fregni F; Benseñor IM
Eur Neuropsychopharmacol; 2013 Nov; 23(11):1530-40. PubMed ID: 23615118
[TBL] [Abstract][Full Text] [Related]
4. Serum levels of brain-derived neurotrophic factor are unchanged after transcranial direct current stimulation in treatment-resistant depression.
Palm U; Fintescu Z; Obermeier M; Schiller C; Reisinger E; Keeser D; Pogarell O; Bondy B; Zill P; Padberg F
J Affect Disord; 2013 Sep; 150(2):659-63. PubMed ID: 23664268
[TBL] [Abstract][Full Text] [Related]
5. Cytokines plasma levels during antidepressant treatment with sertraline and transcranial direct current stimulation (tDCS): results from a factorial, randomized, controlled trial.
Brunoni AR; Machado-Vieira R; Zarate CA; Valiengo L; Vieira EL; Benseñor IM; Lotufo PA; Gattaz WF; Teixeira AL
Psychopharmacology (Berl); 2014 Apr; 231(7):1315-23. PubMed ID: 24150249
[TBL] [Abstract][Full Text] [Related]
6. Plasma levels of soluble TNF receptors 1 and 2 after tDCS and sertraline treatment in major depression: Results from the SELECT-TDCS trial.
Brunoni AR; Machado-Vieira R; Sampaio-Junior B; Vieira EL; Valiengo L; Benseñor IM; Lotufo PA; Carvalho AF; Cho HJ; Gattaz WF; Teixeira AL
J Affect Disord; 2015 Oct; 185():209-13. PubMed ID: 26241865
[TBL] [Abstract][Full Text] [Related]
7. Increase in PAS-induced neuroplasticity after a treatment course of transcranial direct current stimulation for depression.
Player MJ; Taylor JL; Weickert CS; Alonzo A; Sachdev PS; Martin D; Mitchell PB; Loo CK
J Affect Disord; 2014; 167():140-7. PubMed ID: 24968188
[TBL] [Abstract][Full Text] [Related]
8. Transcranial direct current stimulation of 20- and 30-minutes combined with sertraline for the treatment of depression.
Pavlova EL; Menshikova AA; Semenov RV; Bocharnikova EN; Gotovtseva GN; Druzhkova TA; Gersamia AG; Gudkova AA; Guekht AB
Prog Neuropsychopharmacol Biol Psychiatry; 2018 Mar; 82():31-38. PubMed ID: 29233783
[TBL] [Abstract][Full Text] [Related]
9. The sertraline vs. electrical current therapy for treating depression clinical study: results from a factorial, randomized, controlled trial.
Brunoni AR; Valiengo L; Baccaro A; Zanão TA; de Oliveira JF; Goulart A; Boggio PS; Lotufo PA; Benseñor IM; Fregni F
JAMA Psychiatry; 2013 Apr; 70(4):383-91. PubMed ID: 23389323
[TBL] [Abstract][Full Text] [Related]
10. Association of BDNF, HTR2A, TPH1, SLC6A4, and COMT polymorphisms with tDCS and escitalopram efficacy: ancillary analysis of a double-blind, placebo-controlled trial.
Brunoni AR; Carracedo A; Amigo OM; Pellicer AL; Talib L; Carvalho AF; Lotufo PA; Benseñor IM; Gattaz W; Cappi C
Braz J Psychiatry; 2020 Apr; 42(2):128-135. PubMed ID: 31721892
[TBL] [Abstract][Full Text] [Related]
11. Plasma biomarkers in a placebo-controlled trial comparing tDCS and escitalopram efficacy in major depression.
Brunoni AR; Padberg F; Vieira ELM; Teixeira AL; Carvalho AF; Lotufo PA; Gattaz WF; Benseñor IM
Prog Neuropsychopharmacol Biol Psychiatry; 2018 Aug; 86():211-217. PubMed ID: 29894705
[TBL] [Abstract][Full Text] [Related]
12. The sertraline versus electrical current therapy for treating depression clinical study (select-TDCS): results of the crossover and follow-up phases.
Valiengo L; Benseñor IM; Goulart AC; de Oliveira JF; Zanao TA; Boggio PS; Lotufo PA; Fregni F; Brunoni AR
Depress Anxiety; 2013 Jul; 30(7):646-53. PubMed ID: 23625554
[TBL] [Abstract][Full Text] [Related]
13. Comparison of blinding effectiveness between sham tDCS and placebo sertraline in a 6-week major depression randomized clinical trial.
Brunoni AR; Schestatsky P; Lotufo PA; Benseñor IM; Fregni F
Clin Neurophysiol; 2014 Feb; 125(2):298-305. PubMed ID: 23994192
[TBL] [Abstract][Full Text] [Related]
14. Cognitive effects of transcranial direct current stimulation in depression: Results from the SELECT-TDCS trial and insights for further clinical trials.
Brunoni AR; Tortella G; Benseñor IM; Lotufo PA; Carvalho AF; Fregni F
J Affect Disord; 2016 Sep; 202():46-52. PubMed ID: 27253216
[TBL] [Abstract][Full Text] [Related]
15. Rapid antidepressant effects of sleep deprivation therapy correlates with serum BDNF changes in major depression.
Gorgulu Y; Caliyurt O
Brain Res Bull; 2009 Sep; 80(3):158-62. PubMed ID: 19576267
[TBL] [Abstract][Full Text] [Related]
16. International randomized-controlled trial of transcranial Direct Current Stimulation in depression.
Loo CK; Husain MM; McDonald WM; Aaronson S; O'Reardon JP; Alonzo A; Weickert CS; Martin DM; McClintock SM; Mohan A; Lisanby SH;
Brain Stimul; 2018; 11(1):125-133. PubMed ID: 29111077
[TBL] [Abstract][Full Text] [Related]
17. Changes in BDNF serum levels in patients with major depression disorder (MDD) after 6 months treatment with sertraline, escitalopram, or venlafaxine.
Matrisciano F; Bonaccorso S; Ricciardi A; Scaccianoce S; Panaccione I; Wang L; Ruberto A; Tatarelli R; Nicoletti F; Girardi P; Shelton RC
J Psychiatr Res; 2009 Jan; 43(3):247-54. PubMed ID: 18511076
[TBL] [Abstract][Full Text] [Related]
18. Sertraline vs. ELectrical Current Therapy for Treating Depression Clinical Trial--SELECT TDCS: design, rationale and objectives.
Brunoni AR; Valiengo L; Baccaro A; Zanao TA; de Oliveira JF; Vieira GP; Bueno VF; Goulart AC; Boggio PS; Lotufo PA; Bensenor IM; Fregni F
Contemp Clin Trials; 2011 Jan; 32(1):90-8. PubMed ID: 20854930
[TBL] [Abstract][Full Text] [Related]
19. Heart rate variability is a trait marker of major depressive disorder: evidence from the sertraline vs. electric current therapy to treat depression clinical study.
Brunoni AR; Kemp AH; Dantas EM; Goulart AC; Nunes MA; Boggio PS; Mill JG; Lotufo PA; Fregni F; Benseñor IM
Int J Neuropsychopharmacol; 2013 Oct; 16(9):1937-49. PubMed ID: 23759172
[TBL] [Abstract][Full Text] [Related]
20. Serum brain-derived neurotrophic factor, Val66Met polymorphism and open-label SSRI treatment response in Major Depressive Disorder.
Smit AJT; Wu GWY; Rampersaud R; Reus VI; Wolkowitz OM; Mellon SH
Psychoneuroendocrinology; 2024 Jul; 165():107045. PubMed ID: 38636352
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
